PlainRecalls
FDA Drug Moderate Class II Terminated

Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04

Reported: June 5, 2024 Initiated: May 8, 2024 #D-0518-2024

Product Description

Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04

Reason for Recall

Defective container: lack of seal integrity.

Details

Units Affected
51,006 bottles
Distribution
USA Nationwide
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 51,006 bottles.
Why was this product recalled?
Defective container: lack of seal integrity.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 5, 2024. Severity: Moderate. Recall number: D-0518-2024.